Journal Article

Kaposi's Sarcoma-Associated Herpesvirus-Encoded Oncogenes and Oncogenesis

Patrick S. Moore and Yuan Chang

in JNCI Monographs

Volume 1998, issue 23, pages 65-71
Published in print April 1998 | ISSN: 1052-6773
Published online April 1998 | e-ISSN: 1745-6614 | DOI: http://dx.doi.org/10.1093/oxfordjournals.jncimonographs.a024176
Kaposi's Sarcoma-Associated Herpesvirus-Encoded 
Oncogenes and Oncogenesis

Show Summary Details

Preview

Molecular biologic studies of Kaposi's sarcoma-associated herpesvirus (KSHV) have identified a number of potential viral oncogenes that may contribute to KSHV-related neoplasia including a D-type cyclin, an IL-6-like cytokine, and a novel member of the interferon regulatory factor family. KSHV is functionally related to other DNA tumor viruses by encoding specific proteins to inhibit pRb, pro-apoptotic, and interferon-signaling tumor suppressor pathways. The virus appears to employ molecular piracy of cellular regulatory genes as a mechanism to avoid cellular antiviral responses. The transparency of the KSHV genome allows ready identification of the cellular regulatory pathways which may be involved in transformation by KSHV. This provides strong support to the notion that some tumor suppressor pathways serve the dual function of being antiviral pathways to induce cell cycle arrest, apoptosis, and enhanced cell-mediated immunity in response to virus infection. Neoplasia may result from specific viral strategies to overcome these host defense pathways.

Journal Article.  6314 words.  Illustrated.

Subjects: Medical Oncology

Full text: subscription required

How to subscribe Recommend to my Librarian

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.